Evidence map›Paper›PMID 35264212›Full record

ArticleSystematic reviews2022

REalist Synthesis Of non-pharmacologicaL interVEntions for antipsychotic-induced weight gain (RESOLVE) in people living with severe mental illness (SMI).

Ian D Maidment, Geoffrey Wong, Claire Duddy, Rachel Upthegrove, Sheri Oduola, Dan Robotham, Suzanne Higgs, Amy Ahern, Gurkiran Birdi

Open access · goldAbstract read
In one paragraph

Article in Systematic reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Non-pharmacologicaL InterVEntions for Antipsychotic-Induced Weight Gain (RESOLVE) in People Living With Severe Mental Illness: A Realist Synthesis.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Ian D MaidmentCollege of Health and Life Sciences, Aston University, Birmingham, B4 7ET, UK. i.maidment@aston.ac.uk.ORCID 0000-0003-4152-9704
Geoffrey WongNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.
Claire DuddyNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.
Rachel UpthegroveSchool of Psychology, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Sheri OduolaSchool of Health Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
Dan RobothamThe McPin Foundation, 7-14 Great Dover St, London, SE1 4YR, UK.
Suzanne HiggsSchool of Psychology, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Amy AhernMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Gurkiran BirdiCollege of Health and Life Sciences, Aston University, Birmingham, B4 7ET, UK.
Aston University · GBUniversity of Birmingham · GBUniversity of Oxford · GBMcPin Foundation · GBUniversity of Cambridge · GBUniversity of East Anglia · GB

Funding

Department of HealthHealth Services and Delivery Research Programme 131871Medical Research Council MC_UU_00006/6
6 · The paper itself

Abstract

backgroundPeople with severe mental illnesses (SMI) such as schizophrenia die on average 15 to 20 years earlier than everyone else. Two thirds of these deaths are from preventable physical illnesses such as hypertension, cardiovascular disease, and diabetes, which are worsened by weight gain. Antipsychotics are associated with significant weight gain. In REalist Synthesis Of non-pharmacologicaL interVEntions (RESOLVE), a realist synthesis, combining primary and secondary data, will be used to understand and explain how, why, for whom, and in what contexts non-pharmacological interventions can help service users to manage antipsychotic-induced weight gain.

methodsA five-step approach will be used to develop guidance: 1. Developing the initial programme theory An initial (candidate) programme theory, which sets out how and why outcomes occur within an intervention, will be developed. 2. Developing the search The initial programme theory will be refined using academic and grey literature. The proposed initial sampling frame are as follows: Context: people living with SMI, taking antipsychotics, different types of SMI.

interventionnon-pharmacological interventions. MECHANISMS: triggered by the intervention. Outcomes e.g. weight, metabolic adverse events, quality of life, adherence, burden, economic. Searching for relevant documents will continue until sufficient data is found to conclude that the refined programme theory is coherent and plausible. Lived experience (service users) and stakeholder (practitioners) groups will provide feedback. 3. Selection, appraisal and data extraction Documents will be screened against inclusion and exclusion criteria. The text extracted from these documents will be coded as contexts, mechanisms and their relationships to outcomes. 4. Primary data collection Realist interviews with up to 30 service users and informal carers, and 20 practitioners will gather data to support, refute or refine the programme theory. 5. Data analysis A realist logic of analysis will be used to develop and refine the programme theory from secondary and primary data. The analysis will aim to identify practical intervention strategies to change contexts so that key mechanisms are triggered to produce desired outcomes. Guidance will be produced based on these strategies. DISCUSSION: This realist synthesis aims to develop guidance for service users and practitioners on the most appropriate interventional strategies to manage and limit antipsychotic weight gain. SYSTEMATIC REVIEW REGISTRATION: PROSPERO: CRD42021268697.

Indexed as

Antipsychotic AgentsMental DisordersDelivery of Health CareHumansPractice Guidelines as TopicQuality of LifeSystematic Reviews as TopicWeight GainAntipsychotic AgentsAntipsychoticsRealist researchSevere mental illnessWeight gain

Identifiers

PMID35264212
PMCPMC8906356
OpenAlexW4220725371

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.